What is the percentage chance of conception for a 34‑year‑old woman undergoing letrozole induction who ovulated on cycle day 12 and had intercourse on days 10, 11, and 12?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Conception Probability with Letrozole Ovulation Induction

With intercourse on days 10,11, and 12 of the menstrual cycle and confirmed ovulation on day 12, this 34-year-old woman has an approximately 25-30% chance of conception per cycle.

Rationale for This Estimate

The probability of conception depends on the timing of intercourse relative to ovulation and the woman's baseline fertility characteristics:

Optimal Timing Achieved

  • Intercourse occurred on the day of ovulation (day 12) and the two days immediately preceding it, which represents the most fertile window of the menstrual cycle 1
  • Research demonstrates that the probability of a single act of intercourse occurring within the fertile window is approximately 25%, with the peak chance of conception on menstrual day 13 being approximately 9.7% 1
  • Having intercourse on multiple consecutive days within this window substantially increases the cumulative probability of conception compared to a single act 1

Letrozole-Induced Ovulation Context

  • Letrozole is now established as a first-line ovulation induction agent for women with infertility, particularly those with PCOS 2, 3
  • The medication successfully induces ovulation in 80-90% of treatment cycles in women with PCOS 4
  • Letrozole does not appear to increase the risk of congenital malformations or pregnancy loss compared to other ovulation induction methods, though the certainty of evidence remains low 5

Age-Related Fertility Considerations

  • At 34 years old, this woman is within a reasonable reproductive age range, though fertility does begin to decline in the mid-30s
  • Per-cycle pregnancy rates in ovulation induction with letrozole range from 14-20% in clinical trials 4
  • The clinical pregnancy rate with letrozole ovulation induction in similar populations has been reported at approximately 14-20% per cycle 4

Clinical Implications

Expected Outcomes

  • With optimal timing of intercourse relative to ovulation, the per-cycle conception probability is maximized 1
  • If conception does not occur this cycle, cumulative pregnancy rates exceed 84% over multiple cycles with continued letrozole treatment 3
  • Time to pregnancy is optimized when ovulation is successfully achieved, as occurred in this case 3

Important Caveats

  • This estimate assumes normal tubal patency, adequate sperm parameters, and no other fertility factors
  • The actual probability may be lower if there are undiagnosed male factor issues or other fertility impediments
  • Individual cycle fecundability varies based on factors not captured in population-level statistics

References

Related Questions

What is the recommended protocol for using letrozole for ovulation induction in a non‑pregnant, non‑breastfeeding woman with anovulatory infertility (e.g., polycystic ovary syndrome) without severe liver disease or aromatase inhibitor hypersensitivity?
What are the next steps for a patient with polycystic ovary syndrome (PCOS) on letrozole (aromatase inhibitor) induction who experiences ovulation bleeding on day 12, followed by thick transparent white discharge and increased libido from day 23 onwards?
What is the optimal dose and timing of letrozole (aromatase inhibitor) for ovulation induction?
What is the probability of conception in the first menstrual cycle for a healthy couple where the woman is under 35 years old with regular ovulatory cycles and the male partner has normal semen parameters, assuming timed intercourse?
How does letrozole help induce ovulation for individuals with polycystic ovary syndrome (PCOS) or unexplained infertility?
What conditions, besides urinary incontinence, can pelvic floor therapy treat?
What adjuvant therapy is recommended after complete surgical resection of intermediate‑ or high‑risk gastrointestinal stromal tumor (GIST)?
What is the appropriate dosage and application regimen for Faktu ointment (policresulen 50 mg/g and cinchocaine 10 mg/g) for perianal or internal hemorrhoids or fissures?
What is the appropriate treatment for status epilepticus?
What are the guidelines for reducing imatinib (Gleevec) dose in patients who develop moderate to severe toxicity?
What is the recommended olmesartan dose range for adults, and how should it be adjusted in patients with moderate renal impairment (estimated glomerular filtration rate 30–59 mL/min/1.73 m²)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question